NCT06453915View on ClinicalTrials.gov

NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Positron Emission Tomography
Interventions
DRUG

18F-DPA-714

positron emission tomography scan using 18F-DPA-714 as an imaging tracer.

DRUG

18F-FDG

positron emission tomography scan using 18F-FDG as an imaging tracer.

Trial Locations (1)

95816

RECRUITING

UC Davis EXPLORER Molecular Imaging Center, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT06453915 - NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease | Biotech Hunter | Biotech Hunter